Tomoya Manaka

Dr. Tomoya Manaka


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
RIRyosuke Iio
Ryosuke Iio
DUDaiju Ueda
Daiju Ueda
TMToshimasa Matsumoto
Toshimasa Matsumoto
TMTomoya Manaka
Tomoya Manaka
KNKatsumasa Nakazawa
Katsumasa Nakazawa
HNHiroaki Nakamura
Hiroaki Nakamura

29 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RIRyosuke Iio
Ryosuke Iio
TMTomoya Manaka
Tomoya Manaka
KNKatsumasa Nakazawa
Katsumasa Nakazawa
YHYoshihiro Hirakawa
Yoshihiro Hirakawa
YIYoichi Ito
Yoichi Ito
HNHiroaki Nakamura
Hiroaki Nakamura
Shoulder disorders occasionally cause intractable pain. Central sensitization (CS) may be involved in such pain. Identifying risk factors associated with CS is crucial for effective pain control. This study aimed to determine the effects of shoulder osteoarthritis and rotator cuff tears (RCT) on CS and associated factors. This study included patients evaluated for CS using the Central Sensitization Inventory (CSI) before surgery for shoulder osteoarthritis, RCT, or cuff tear arthropathy. Patients with a CSI score of 40 or higher were defined as having CS. The relationships between glenohumeral osteoarthritis (GHOA), RCT size, and CS were statistically analyzed. Multiple regression analysis was performed to examine the factors affecting CSI scores. Subjects included 167 patients: 131 patients had RCT without GHOA, 23 had GHOA with RCT, and 13 had GHOA without RCT. The GHOA group had a significantly higher CSI score (27.5 [10.8–40.5] vs. 18.0 [10.0–27.5]) and CS prevalence (27.8% vs. 8.4%) than the RCT without GHOA group. There was no significant correlation between RCT size and CSI scores. Multiple regression analysis showed that female sex, severe pain, and long pain duration were associated with higher CSI scores. Considering the risk factors for CS might be helpful in shoulder treatment.

27 May 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
RIRyosuke Iio
Ryosuke Iio
TMTomoya Manaka
Tomoya Manaka
NTNaoki Takada
Naoki Takada
KOKumi Orita
Kumi Orita
KNKatsumasa Nakazawa
Katsumasa Nakazawa
HNHiroaki Nakamura
Hiroaki Nakamura

25 November 2022 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
YHYoshihiro Hirakawa
Yoshihiro Hirakawa
TMTomoya Manaka
Tomoya Manaka
YIYoichi Ito
Yoichi Ito
KNKatsumasa Nakazawa
Katsumasa Nakazawa
RIRyosuke Iio
Ryosuke Iio
PCPhilippe Collin
Philippe Collin

22 February 2023 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
YHYoshihiro Hirakawa
Yoshihiro Hirakawa
TMTomoya Manaka
Tomoya Manaka
YIYoichi Ito
Yoichi Ito
KNKatsumasa Nakazawa
Katsumasa Nakazawa
RIRyosuke Iio
Ryosuke Iio
HNHiroaki Nakamura
Hiroaki Nakamura

14 May 2025 in JSES International
Verified
Journal Article
Open access
YHYoshihiro Hirakawa
Yoshihiro Hirakawa
TMTomoya Manaka
Tomoya Manaka
KNKatsumasa Nakazawa
Katsumasa Nakazawa
YIYoichi Ito
Yoichi Ito
STSo Taniguchi
So Taniguchi
HTHidetomi Terai
Hidetomi Terai
Although the postoperative outcomes of reverse total shoulder arthroplasty (rTSA) are favorable, few studies have examined the impact of previous arthroscopic rotator cuff repair (ARCR) on rTSA outcomes in detail. This study aimed to evaluate and compare the short-term outcomes of rTSA in patients without previous ARCR (control group) and those with a history of ARCR (previous ARCR group). By focusing on postoperative range of motion, clinical scores, and muscle strength over a minimum 2-year follow-up period, we sought to reveal critical insights into how previous ARCR influences recovery trajectories. We analyzed all patients diagnosed with cuff tear arthropathy or massive rotator cuff tears who underwent rTSA between April 2014 and March 2021, with at least two years of follow-up. The follow-up rate was 81.4% (228/280). The exclusion criteria included revision arthroplasty, infection, previous open surgery, and additional tendon transfer. The key metrics assessed were range of motion, American Shoulder and Elbow Surgeons (ASES) score, Constant score (CS), visual analog scale score for pain, and muscle strength. In total, 228 patients were included: 182 (mean age: 76 years) in the control group and 46 (mean age: 75 years) in the previous ARCR group. Active elevation improved significantly from 77° to 121° in the control group and from 81° to 116° in the previous ARCR group. External rotation at the side showed no significant change in either group, whereas internal rotation worsened postoperatively in both groups. The ASES, CS, and visual analog scale scores showed significant improvements 2 years postoperatively in both groups. However, the control group had significantly higher postoperative ASES and CS scores than those in the previous ARCR group. Muscle strength significantly improved in the control group but not in the previous ARCR group. Postoperative muscle strength improvement was not observed in patients undergoing rTSA with a history of ARCR, and their postoperative clinical outcomes were inferior to those undergoing rTSA without a history of ARCR. This deficiency in muscle strength improvement may contribute to the differences in clinical scores, a factor that surgeons need to consider.